Literature DB >> 14986264

Detection of influenza antigen with rapid antibody-based tests after intranasal influenza vaccination (FluMist).

Tanya Ali1, Nathaniel Scott, Wendy Kallas, Mary Ellen Halliwell, Carol Savino, Eric Rosenberg, MaryJane Ferraro, Elizabeth Hohmann.   

Abstract

Rapid tests for influenza antigen detection are frequently used, but it is not known how receipt of intranasal influenza vaccine affects results of these tests. We tested healthy adults who received either intranasal or intramuscular influenza vaccine. Of the 14 intranasal vaccine recipients, 7 (50%) had a direct fluorescent antibody test (DFA) result and 2 (14%) had an enzyme immunoassay (EIA) result that was positive for influenza antigen within 7 days after vaccination. No subjects had positive EIA results on day 12 or 13 after vaccination. For some intranasal vaccine recipients, rapid influenza-antigen detection tests yield positive results within 1 week after vaccination.

Mesh:

Substances:

Year:  2004        PMID: 14986264     DOI: 10.1086/382887

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

1.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

2.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

Review 3.  Immunization after kidney transplantation-what is necessary and what is safe?

Authors:  Camille N Kotton
Journal:  Nat Rev Nephrol       Date:  2014-07-29       Impact factor: 28.314

4.  Recommendations on the use of live, attenuated influenza vaccine (FluMist®): Supplemental Statement on Seasonal Influenza Vaccine for 2011-2012 An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2011-11-30

5.  Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Scott A Harper; John S Bradley; Janet A Englund; Thomas M File; Stefan Gravenstein; Frederick G Hayden; Allison J McGeer; Kathleen M Neuzil; Andrew T Pavia; Michael L Tapper; Timothy M Uyeki; Richard K Zimmerman
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

Review 6.  Vaccination strategies in patients with solid organ transplant: evidences and future perspectives.

Authors:  Youn Jeong Kim; Sang Il Kim
Journal:  Clin Exp Vaccine Res       Date:  2016-07-29

Review 7.  Vaccinations in kidney transplant recipients: Clearing the muddy waters.

Authors:  Swati Arora; Gretchen Kipp; Nitin Bhanot; Kalathil K Sureshkumar
Journal:  World J Transplant       Date:  2019-01-16

8.  Diagnostic discrimination of live attenuated influenza vaccine strains and community-acquired pathogenic strains in clinical samples.

Authors:  Nikki E Freed; Christopher A Myers; Kevin L Russell; Elizabeth A Walter; Marina Irvine; Robert G Coon; David Metzgar
Journal:  Mol Cell Probes       Date:  2006-09-08       Impact factor: 2.365

9.  The Saudi Thoracic Society guidelines for influenza vaccinations.

Authors:  Mohammed O Zeitouni; Ali M Al Barrak; Mohamed S Al-Moamary; Nasser S Alharbi; Majdy M Idrees; Abdullah A Al Shimemeri; Mohamed S Al-Hajjaj
Journal:  Ann Thorac Med       Date:  2015 Oct-Dec       Impact factor: 2.219

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.